Fabrib
Forumer storico
Peregrine Pharma reports FQ2 results
Dec 11 2015, 06:25 ET | About: Peregrine Pharmaceuticals ... (PPHM) | By: Mamta Mayani, SA News Editor Contact this editor with comments or a news tip
Peregrine Pharmaceuticals (PPHM +1.7%) FQ2 results: Revenues: $9.5M (+50.8%); R&D Expense: $14.2M (+42.0%); SG&A: $4.4M (+2.3%); Operating Loss: ($13.8M) (-14.0%); Net Loss: ($13.2M) (-9.1%); Loss Per Share: ($0.07) (unch); Quick Assets: $72M (+5.9%).FY2016 Guidance: Third-party contract manufacturing revenue: $35M - 40M from $30M - $35M.
Dec 11 2015, 06:25 ET | About: Peregrine Pharmaceuticals ... (PPHM) | By: Mamta Mayani, SA News Editor Contact this editor with comments or a news tip
Peregrine Pharmaceuticals (PPHM +1.7%) FQ2 results: Revenues: $9.5M (+50.8%); R&D Expense: $14.2M (+42.0%); SG&A: $4.4M (+2.3%); Operating Loss: ($13.8M) (-14.0%); Net Loss: ($13.2M) (-9.1%); Loss Per Share: ($0.07) (unch); Quick Assets: $72M (+5.9%).FY2016 Guidance: Third-party contract manufacturing revenue: $35M - 40M from $30M - $35M.